Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2007-04-20 09:02 |
Pharming announces first quarter 2007 results
|
English | 119.3 KB | ||
| 2007-02-16 08:54 |
Pharming announces annual results 2006
|
English | 112.8 KB | ||
| 2007-02-16 08:54 |
Pharming announces annual results 2006
|
English | 109.9 KB | ||
| 2006-06-29 08:05 |
PHARMING STRENGTHENS INTELLECTUAL PROPERTY POSITION FOR RECOMBINANT HUMAN C1 IN…
|
English | 70.4 KB | ||
| 2006-06-29 08:05 |
PHARMING STRENGTHENS INTELLECTUAL PROPERTY POSITION FOR RECOMBINANT HUMAN C1 IN…
|
English | 59.6 KB | ||
| 2006-06-14 08:12 |
PHARMING RECIEVES ORPHAN DRUG DESIGNATIONS FOR RHC1INH FROM US FDA
|
English | 61.0 KB | ||
| 2006-06-14 08:12 |
PHARMING RECIEVES ORPHAN DRUG DESIGNATIONS FOR RHC1INH FROM US FDA
|
English | 63.6 KB | ||
| 2006-05-16 08:47 |
PHARMING TO PARTICIPATE IN DUTCH CONSORTIUM ON BIOMEDICAL MATERIALS
|
Dutch | 60.0 KB | ||
| 2006-05-16 08:47 |
PHARMING TO PARTICIPATE IN DUTCH CONSORTIUM ON BIOMEDICAL MATERIALS
|
Dutch | 61.7 KB | ||
| 2006-04-26 08:42 |
PHARMING ANNOUNCES FIRST QUARTER 2006 RESULTS-Reports on solid cash position an…
|
English | 105.5 KB | ||
| 2006-04-26 08:42 |
PHARMING ANNOUNCES FIRST QUARTER 2006 RESULTS-Reports on solid cash position an…
|
English | 104.3 KB | ||
| 2006-04-24 08:31 |
DNage, Loders Croklaan, BG Medicine en Erasumus MC kondigen samenwerking aan op…
|
Dutch | 180.5 KB | ||
| 2006-04-24 08:31 |
DNage, Loders Croklaan, BG Medicine en Erasumus MC kondigen samenwerking aan op…
|
Dutch | 181.3 KB | ||
| 2006-03-24 09:37 |
Pharming announces acquisition of DNage B.V.
|
English | 115.8 KB | ||
| 2006-03-24 09:37 |
Pharming announces acquisition of DNage B.V.
|
English | 121.2 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
